Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone added to bupivacaine for postoperative opioid reduction in upper abdominal surgery
PACTR202203717131021Phase 4Recruiting
- Sponsor
- National Liver Institute
- Start
- Sep 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexamethasone and bupivacaine in postoperative pain (2 arms), sponsored by National Liver Institute. Primary endpoint: Total narcotics consumption. Started Sep 2021; status: recruiting.
02
Drugs
dexamethasonebupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on PACTR202203717131021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202203717131021.